Product Licensing & Distribution Opportunities
Aptalis Pharmaceutical Technologies has a number of Rx and OTC products available for licensing. In general, these products are new formulations of existing drugs that incorporate one or more of our proprietary drug delivery technologies. We license these products to pharmaceutical companies for marketing throughout the world.
Currently more than 40 products have been developed by Aptalis Pharmaceutical Technologies and are commercialized by our partners in different countries around the world. These products span a range of key therapeutic categories, including:
Contact Us (partners@AptalisPharma.com) to discuss available licensing opportunities.
Aptalis Pharmaceutical Technologies develops products for our partners and for our own portfolio utilizing our core technology platforms:
Through our collaboration agreements, we have successfully applied our technologies to drug products in a diverse range of therapeutic areas, resulting in a broad portfolio of Rx and OTC products available for out-licensing.
Our partnership process provides our clients with an experienced management team across all functions and stages of the product development cycle. We have a multinational infrastructure and integrated R&D and manufacturing facilities in the U.S. and Europe, allowing us to offer global solutions to companies in various regions around the world.
In addition, our global business development and licensing teams strive to offer flexible deal structures to maximize our partners’ interests.
To meet our partners’ business needs, we offer resources for the development of new product formulations, or licensing availability of existing product formulations.
We have established partnerships with major pharmaceutical companies, including Eisai, GlaxoSmithKline, Nycomed, Pfizer, Samil, sanofi-aventis, Teva, UCB, Abbott, Actavis, Adcock Ingram, Aliud, Bayer, Bristol-Myers Squibb, Cephalon, Daewoong, Johnson & Johnson, Menarini, Merck, and Novartis. These relationships are based on either co-development of products using our partners’ drug and our pharmaceutical technologies, or the licensing and distribution of our internally developed products.
Partner in the lifecycle management of your product portfolio.
Contact us atwww.AptalisPharmaceuticalTechnologies.com/contact.html